Live Breaking News & Updates on Australian Department Of Health Therapeutic Goods Administration

Stay updated with breaking news from Australian department of health therapeutic goods administration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Heritage Cannabis Announces Supply Agreements and First Shipment of Opticann Medical Products to Aus

Opticann completes shipments of CBD filmstrips formulated with Heritage CBD and manufactured using IntelGenx VersaFilm® technologyTORONTO (BUSINESS WIRE) Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), is pleased to announce its subsidiary Opticann has signed two supply a. ....

Grand View , Umar Syed , David Schwede , Pura Vida , Intelgenx Versafilm , View Research , Intelgenx Corp , Canadian Securities Exchange , Australian Department Of Health Therapeutic Goods Administration , Heritage Cannabis Holdings Corp , Heritage Cannabis Holdings , Medical Division , Australian Department , Therapeutic Goods Administration ,

Covid-19: What you need to know about the AstraZeneca vaccine and the rare blood clot risk


Explainer: Covid-19 vaccine AstraZeneca is making headlines overseas due to a very rare side effect of blood clotting. This vaccine is not currently being used in NZ. Here s everything you need to know.
Global Covid-19 vaccine roll-outs are poking holes in the efficacy of the doses on the market. The AstraZeneca vaccine, which has not yet been approved for use in New Zealand, has a “possible link” to potentially fatal blood clots.
The clots, called cerebral venous sinus thrombosis (CVST), occur in the brain’s venous sinuses and can prevent blood from draining out of the brain.
READ MORE:
The AstraZeneca coronavirus vaccine has made headlines recently due to a possible link to blood clots. ....

United Kingdom , City Of , United States , New Zealand , South Africa , Adam Finn , Soren Brostrom , Chris James , David Murdoch , Johnson Janssen , Drug Administration , National Safety Council , Australian Department Of Health Therapeutic Goods Administration , World Health Organisation , University Of Otago , European Union , European Medicines Agency , British Medical Association Public Health Medicine Committee , University Of Bristol , Health Dr Ashley Bloomfield , Infection Group , Healthcare Products Regulatory Agency , United Kingdom Government , Peter English , British Medical Association , Public Health Medicine Committee ,

Covid-19: What you need to know about the AstraZeneca vaccine and its rare side effect of blood clotting


The only vaccine being administered here is the Pfizer/BioNTech jab. At a press conference on Wednesday, Director-General of Health Dr Ashley Bloomfield said there were no new safety concerns with the vaccine in New Zealand.
On Wednesday, New Zealand’s medicines regulator MedSafe also published its initial report on the safety monitoring of the roll-out of the Pfizer/BioNTech vaccine here.
Blood clotting a ‘very rare’ side effect
The EMA s safety committee reviewed some extremely rare cases of unusual blood clots in people who had received the jab in Europe. The clots, called cerebral venous sinus thrombosis (CVST), occur in the brain’s venous sinuses and can prevent blood from draining out of the brain. ....

United Kingdom , City Of , New Zealand , Adam Finn , Chris James , David Murdoch , Janssen Pharmaceutica , Australian Department Of Health Therapeutic Goods Administration , World Health Organisation , University Of Otago , European Medicines Agency , British Medical Association Public Health Medicine Committee , University Of Bristol , Infection Group , Healthcare Products Regulatory Agency , Health Dr Ashley Bloomfield , United Kingdom Government , Peter English , British Medical Association , Public Health Medicine Committee , Medsafe New Zealand , Australian Department , Therapeutic Goods Administration , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , புதியது ஜீலாந்து ,

Heritage Cannabis Reports First Quarter 2021 Financial Results


Heritage Cannabis Reports First Quarter 2021 Financial Results
“Heritage”
or the
“Company”), today announced its financial results as at and for the three months ended January 31, 2021 (“
Q1 2021”). All figures are in Canadian dollars unless otherwise noted.
“As we have stated previously, first quarter results do not include the positive impacts of the Premium 5 acquisition given the transaction closed at the end of the quarter, nor does it include results from our initial medical launch which will begin later this month,” stated Clint Sharples, Chief Executive Officer of Heritage. “As we move forward, we expect to see continued acceleration in both our medical and recreational product divisions with the addition of Premium 5 starting to have a material effect in Canada. Additionally, with our imminent launch in the multi-billion dollar U.S. market, and continued growth from our Pura Vida and Purefarma brands we expec ....

United States , Province Of Saskatchewan , United Kingdom , Purefarma Hemplixir , Pura Vida , Kelly Castledine , Clint Sharples , Intelgenx Versafilm , Ontario Cannabis Store , Cannabr Exports Corp Canna , Intelgenx Corp , Brazil Health Authority , Opticann Inc , Davidson Company , Cannacure Corp , Gaming Authority , Canadian Securities Exchange , National Instrument , Pura Vida Daybreak Sativa Honey Oil , Honey Oil , Shoppers Drug Mart , Australian Department Of Health Therapeutic Goods Administration , Brazil Health Authority Anvisa , Heritage Cannabis Holdings Corp , Voyage Cannabis Corp , Nightfall Indica Honey Oil ,